{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:05:33Z","timestamp":1790730333287,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s12325-024-02788-y","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T04:02:54Z","timestamp":1708056174000},"page":"1481-1495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["7-Year Efficacy and Safety of iStent inject Trabecular Micro-Bypass in Combined and Standalone Usage"],"prefix":"10.1007","volume":"41","author":[{"given":"Fritz H.","family":"Hengerer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd U.","family":"Auffarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Conrad-Hengerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"2","key":"2788_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","volume":"130","author":"G Gazzard","year":"2023","unstructured":"Gazzard G, Konstantakopoulou E, Garway-Heath D, Adeleke M, Vickerstaff V, Ambler G, Hunter R, Bunce C, Nathwani N, Barton K, LiGHT Trial Study Group. Laser in glaucoma and ocular hypertension (LiGHT) trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension. Ophthalmology. 2023;130(2):139\u201351.","journal-title":"Ophthalmology"},{"issue":"21","key":"2788_CR2","doi-asserted-by":"publisher","first-page":"00032","DOI":"10.1016\/j.ogla.2021.01.004","volume":"S2589\u20134196","author":"MV Boland","year":"2021","unstructured":"Boland MV, Corcoran KJ, Lee AY. Changes in performance of glaucoma surgeries 1994 through 2017 based on claims and payment data for United States medicare beneficiaries. Ophthalmol Glaucoma. 2021;S2589\u20134196(21):00032\u20136. https:\/\/doi.org\/10.1016\/j.ogla.2021.01.004.","journal-title":"Ophthalmol Glaucoma"},{"key":"2788_CR3","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s40123-023-00831-9","volume":"12","author":"NM Radcliffe","year":"2023","unstructured":"Radcliffe NM, Shah M, Samuelson TW. Challenging the \u2018Topical Medications-First\u2019 approach to glaucoma: a treatment paradigm in evolution. Ophthalmol Ther. 2023;12:2823\u201339.","journal-title":"Ophthalmol Ther"},{"key":"2788_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","volume":"153","author":"SE Skalicky","year":"2012","unstructured":"Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol. 2012;153:1-9.e2.","journal-title":"Am J Ophthalmol"},{"key":"2788_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1477-7525-1-75","volume":"1","author":"JP Nordmann","year":"2003","unstructured":"Nordmann JP, Auzanneau N, Ricard S, Berdeaux G. Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003;1:75.","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"2788_CR6","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","volume":"112","author":"DC Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112(11):1446\u201354.","journal-title":"Arch Ophthalmol"},{"key":"2788_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2019.02.003","volume":"203","author":"MJ Muniesa","year":"2019","unstructured":"Muniesa MJ, Ezpeleta J, Ben\u00edtez I. Fluctuations of the intraocular pressure in medically versus surgically treated glaucoma patients by a contact lens sensor. Am J Ophthalmol. 2019;203:1\u201311.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2788_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","volume":"140","author":"BL Nordstrom","year":"2005","unstructured":"Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140(4):598\u2013606.","journal-title":"Am J Ophthalmol"},{"key":"2788_CR9","unstructured":"Ahmed IIK, Sarkisian SR, Gallardo MJ, Brubaker JW, Grover DS. Prospective Pivotal Trial: Standalone Multiple Trabecular Micro-Bypass Stents (iStent infinite) for Uncontrolled Glaucoma. Platform Presentation at Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS), San Diego, CA: May 5, 2023."},{"key":"2788_CR10","unstructured":"Businesswire.com Press Release August 23, 2021. \u201cGlaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent Technologies.\u201d https:\/\/www.businesswire.com\/news\/home\/20210823005049\/en\/Glaukos-Announces-Market-Leading-Clinical-Milestone-of-200-Peer-Reviewed-Publications-on-iStent%C2%AE-Technologies. Accessed 15 June 2023."},{"issue":"2","key":"2788_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40123-018-0152-8","volume":"7","author":"FH Hengerer","year":"2018","unstructured":"Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Prospective, non-randomized, 36-month study of second-generation trabecular micro-bypass stents with phacoemulsification in various types of glaucoma. Ophthalmol Ther. 2018;7(2):405\u201315.","journal-title":"Ophthalmol Ther"},{"issue":"7","key":"2788_CR12","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1007\/s12325-019-00984-9","volume":"36","author":"FH Hengerer","year":"2019","unstructured":"Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Second-generation trabecular micro-bypass stents as standalone treatment for glaucoma: a 36-month prospective study. Adv Ther. 2019;36(7):1606\u201317.","journal-title":"Adv Ther"},{"issue":"3","key":"2788_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s12325-021-02039-4","volume":"39","author":"FH Hengerer","year":"2022","unstructured":"Hengerer FH, Auffarth GU, Conrad-Hengerer I. iStent inject trabecular micro-bypass with or without cataract surgery yields sustained 5-year glaucoma control. Adv Ther. 2022;39(3):1417\u201331.","journal-title":"Adv Ther"},{"issue":"6","key":"2788_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","volume":"126","author":"TW Samuelson","year":"2019","unstructured":"Samuelson TW, Sarkisian SR Jr, Lubeck DM, Stiles MC, Duh Y-J, Romo EA, Giamporcaro JE, Hornbeak DM, Katz LJ. For the iStent inject Study Group, prospective, randomized, controlled pivotal trial of iStent inject trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126(6):811\u201321.","journal-title":"Ophthalmology"},{"key":"2788_CR15","first-page":"499","volume":"8","author":"K Hunter","year":"2014","unstructured":"Hunter K, Fjield T, Heitzmann H, Shandas R, Kahook M. Characterization of micro- invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling. Clin Ophthalmol. 2014;8:499\u2013506.","journal-title":"Clin Ophthalmol"},{"key":"2788_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ogla.2018.11.010","volume":"2","author":"AS Huang","year":"2019","unstructured":"Huang AS, Penteado RC, Papoyan V, Voskanyan L, Weinreb RN. Aqueous angiographic outflow improvement after trabecular micro-bypass in glaucoma patients. Ophthalmol Glaucoma. 2019;2:11\u201321.","journal-title":"Ophthalmol Glaucoma"},{"issue":"7","key":"2788_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/IJG.0000000000001805","volume":"30","author":"PR Healey","year":"2021","unstructured":"Healey PR, Clement CI, Kerr NM, Tilden D, Aghajanian L. Standalone iStent trabecular micro-bypass glaucoma surgery: a systematic review and meta-analysis. J Glaucoma. 2021;30(7):606\u201320.","journal-title":"J Glaucoma"},{"key":"2788_CR18","doi-asserted-by":"publisher","DOI":"10.1159\/000531077","author":"F Kahale","year":"2023","unstructured":"Kahale F, Chanbour W, El Zein L, Brenner J, You JY, Melki S. Phacoemulsification with and without iStent: a systematic review and meta-analysis of comparative studies. Ophthalmic Res. 2023. https:\/\/doi.org\/10.1159\/000531077.","journal-title":"Ophthalmic Res"},{"issue":"1","key":"2788_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40662-021-00263-1","volume":"8","author":"A Salimi","year":"2021","unstructured":"Salimi A, Watt H, Harasymowycz P. Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results. Eye Vis (Lond). 2021;8(1):43.","journal-title":"Eye Vis (Lond)"},{"key":"2788_CR20","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.2147\/OPTH.S373290","volume":"16","author":"C Clement","year":"2022","unstructured":"Clement C, Howes F, Ioannidis A, Shiu M, Manning D, Lusthaus JA, Skalicky SE, Goodwin TW. Multicenter effectiveness and disease stability through 3 years after iStent trabecular micro-bypass with phacoemulsification in glaucoma and ocular hypertension. Clin Ophthalmol. 2022;16:2955\u201368.","journal-title":"Clin Ophthalmol"},{"key":"2788_CR21","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2147\/OPTH.S247910","volume":"14","author":"TJ Ferguson","year":"2020","unstructured":"Ferguson TJ, Mechels KB, Dockter Z, et al. iStent trabecular microbypass stent implantation with phacoemulsification in patients with open-angle glaucoma: 6-year outcomes. Clin Ophthalmol. 2020;14:1859\u201366.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"2788_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ogla.2019.03.004","volume":"2","author":"RD Fechtner","year":"2019","unstructured":"Fechtner RD, Voskanyan L, Vold SD, Tetz M, Auffarth G, Masood I, Au L, Khouri AS, Ahmed IIK, Saheb H. Five-year, prospective, randomized, multi-surgeon trial of two trabecular bypass stents versus prostaglandin for newly-diagnosed open-angle glaucoma. Ophthalmol Glaucoma. 2019;2(3):156\u201366.","journal-title":"Ophthalmol Glaucoma"},{"key":"2788_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40662-020-00194-3","volume":"7","author":"TJ Ferguson","year":"2020","unstructured":"Ferguson TJ, Dockter Z, Bleeker A, Karpuk KK, Schweitzer J, Ibach MJ, Berdahl JP. iStent inject trabecular microbypass stent implantation with cataract extraction in open-angle glaucoma: early clinical experience. Eye Vis (Lond). 2020;7:28.","journal-title":"Eye Vis (Lond)"},{"issue":"3","key":"2788_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/ceo.14048","volume":"50","author":"DP Holmes","year":"2022","unstructured":"Holmes DP, Clement CI, Nguyen V, Healey PR, Lim R, White A, Yuen J, Lawlor M. Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery. Clin Exp Ophthalmol. 2022;50(3):303\u201311.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"2788_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/IJG.0000000000000825","volume":"27","author":"T Ferguson","year":"2018","unstructured":"Ferguson T, Swan R, Ibach M, Schweitzer J, Sudhagoni R, Berdahl JP. Evaluation of a trabecular microbypass stent with cataract extraction in severe primary open-angle glaucoma. J Glaucoma. 2018;27(1):71\u20136.","journal-title":"J Glaucoma"},{"issue":"4","key":"2788_CR26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jcrs.2018.11.005","volume":"45","author":"TJ Ferguson","year":"2019","unstructured":"Ferguson TJ, Ibach M, Schweitzer J, Karpuk K, Stephens JD, Sudhagoni R, Berdahl JP. Trabecular microbypass stent implantation in pseudophakic eyes with open-angle glaucoma: Long-term results. J Cataract Refract Surg. 2019;45(4):414\u201320.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"2788_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/IJG.0000000000001716","volume":"30","author":"A Salimi","year":"2021","unstructured":"Salimi A, Watt H, Harasymowycz P. Three-year outcomes of second-generation trabecular micro-bypass stents (iStent inject) with phacoemulsification in various glaucoma subtypes and severities. J Glaucoma. 2021;30(3):266\u201375.","journal-title":"J Glaucoma"},{"issue":"9","key":"2788_CR28","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/j.jcrs.0000000000000243","volume":"46","author":"TJ Ferguson","year":"2020","unstructured":"Ferguson TJ, Swan RJ, Bleeker A, et al. Trabecular microbypass stent implantation in pseudoexfoliative glaucoma: long-term results. J Cataract Refract Surg. 2020;46(9):1284\u20139.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"2788_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/ceo.13638","volume":"48","author":"TJ Ferguson","year":"2020","unstructured":"Ferguson TJ, Ibach M, Schweitzer J, Karpuk KL, Stephens JD, Berdahl JP. Trabecular microbypass stent implantation with cataract extraction in pigmentary glaucoma. Clin Exp Ophthalmol. 2020;48(1):37\u201343.","journal-title":"Clin Exp Ophthalmol"},{"key":"2788_CR30","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.2147\/OPTH.S302684","volume":"15","author":"RAP Guedes","year":"2021","unstructured":"Guedes RAP, Gravina DM, Paletta Guedes VM, Chaoubah A. Two-year comparative outcomes of first- and second-generation trabecular micro-bypass stents with cataract surgery. Clin Ophthalmol. 2021;15:1861\u201373.","journal-title":"Clin Ophthalmol"},{"key":"2788_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40662-019-0169-7","volume":"7","author":"R Neuhann","year":"2020","unstructured":"Neuhann R, Neuhann T. Second-generation trabecular micro-bypass stent implantation: retrospective analysis after 12- and 24-month follow-up. Eye Vis (Lond). 2020;7:1.","journal-title":"Eye Vis (Lond)"},{"key":"2788_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ajo.2020.12.032","volume":"224","author":"A Salimi","year":"2021","unstructured":"Salimi A, Abu-Nada M, Harasymowycz P. Matched cohort study of cataract surgery with and without trabecular microbypass stent implantation in primary angle-closure glaucoma. Am J Ophthalmol. 2021;224:310\u201320.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"2788_CR33","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40123-020-00266-6","volume":"9","author":"A Salimi","year":"2020","unstructured":"Salimi A, Clement C, Shiu M, Harasymowycz P. Second-generation trabecular micro-bypass (iStent inject) with cataract surgery in eyes with normal-tension glaucoma: one-year outcomes of a multi-centre study. Ophthalmol Ther. 2020;9(3):585\u201396.","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"2788_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/ceo.13763","volume":"48","author":"J Berdahl","year":"2020","unstructured":"Berdahl J, Voskanyan L, Myers JS, Katz LJ, Samuelson TW. iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes. Clin Exp Ophthalmol. 2020;48(6):767\u201374.","journal-title":"Clin Exp Ophthalmol"},{"key":"2788_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/OPTH.S235293","volume":"14","author":"R Lindstrom","year":"2020","unstructured":"Lindstrom R, Sarkisian SR, Lewis R, Hovanesian J, Voskanyan L. Four-year outcomes of two second-generation trabecular micro-bypass stents in patients with open-angle glaucoma on one medication. Clin Ophthalmol. 2020;14:71\u201380.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"2788_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40662-022-00294-2","volume":"9","author":"BCH Ang","year":"2022","unstructured":"Ang BCH, Chiew W, Yip VCH, Chua CH, Han WS, Tecson IOC, Ogle JJ, Lim BA, Hee OK, Tay ELY, Yong VKY, Wong HT, Yip LWL. Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma. Eye Vis (Lond). 2022;9(1):27.","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"2788_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40123-021-00424-4","volume":"11","author":"RA Paletta Guedes","year":"2022","unstructured":"Paletta Guedes RA, Gravina DM, Paletta Guedes VM, Chaoubah A. Standalone Implantation of 2\u20133 trabecular micro-bypass stents (iStent inject \u00b1 iStent) as an alternative to trabeculectomy for moderate-to-severe glaucoma. Ophthalmol Ther. 2022;11(1):271\u201392.","journal-title":"Ophthalmol Ther"},{"key":"2788_CR38","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.2147\/OPTH.S283587","volume":"14","author":"RC Silveira Seixas","year":"2020","unstructured":"Silveira Seixas RC, Balbino M, Basile Neto A, de Alcantara Almeida Costa A, Jord\u00e3o MLS, Russ HHA. Mid-term evaluation of iStent Inject\u00ae trabecular micro-bypass stent implantation with or without phacoemulsification: a retrospective study. Clin Ophthalmol. 2020;14:4403\u201313.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"2788_CR39","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s40123-021-00380-z","volume":"10","author":"A Al Habash","year":"2021","unstructured":"Al Habash A, Otaif W. Surgical outcomes of combined 2nd-generation trabecular microbypass (iStent Inject) and cataract surgery for the treatment of primary open-angle glaucoma in the Saudi Population. Ophthalmol Ther. 2021;10(4):923\u201333.","journal-title":"Ophthalmol Ther"},{"key":"2788_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/OPTH.S239103","volume":"14","author":"AS Ioannidis","year":"2020","unstructured":"Ioannidis AS, Toteberg-Harms M, Hamann T, Hodge C. Refractive outcomes after trabecular micro-bypass stents (iStent Inject) with cataract extraction in open-angle glaucoma. Clin Ophthalmol. 2020;14:517\u201324.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"2788_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40123-019-00208-x","volume":"8","author":"D Manning","year":"2019","unstructured":"Manning D. Real-world case series of iStent or iStent Inject trabecular micro-bypass stents combined with cataract surgery. Ophthalmol Ther. 2019;8(4):549\u201361.","journal-title":"Ophthalmol Ther"},{"key":"2788_CR42","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.2147\/OPTH.S316270","volume":"15","author":"IP Singh","year":"2021","unstructured":"Singh IP, Sarkisian S, Hornbeak D, Katz LJ, Samuelson T, iStent inject Study Group. Treatment success across different levels of preoperative disease burden: stratified 2-year outcomes from the pivotal trial of iStent inject\u00ae trabecular micro-bypass in primary open-angle glaucoma and cataract. Clin Ophthalmol. 2021;15:3231\u201340.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"2788_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12325-014-0095-y","volume":"31","author":"L Voskanyan","year":"2014","unstructured":"Voskanyan L, Garcia-Feijoo J, Belda J, Fea A, J\u00fcnemann A, Baudouin C, Synergy Study Group. Prospective, unmasked evaluation of the iStent inject system for open-angle glaucoma: synergy trial. Adv Ther. 2014;31(2):189\u2013201.","journal-title":"Adv Ther"},{"key":"2788_CR44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.007","volume":"229","author":"TW Samuelson","year":"2021","unstructured":"Samuelson TW, Singh IP, Williamson BK, Falvey H, Lee WC, Odom D, McSorley D, Katz LJ. Quality of life in primary open-angle glaucoma and cataract: an analysis of VFQ-25 and OSDI from the iStent inject\u00ae pivotal trial. Am J Ophthalmol. 2021;229:220\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2788_CR45","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s40123-020-00290-6","volume":"9","author":"JA Schweitzer","year":"2020","unstructured":"Schweitzer JA, Hauser WH, Ibach M, et al. Prospective interventional cohort study of ocular surface disease changes in eyes after trabecular micro-bypass Stent(s) implantation (iStent or iStent inject) with phacoemulsification. Ophthalmol Ther. 2020;9(4):941\u201353.","journal-title":"Ophthalmol Ther"},{"issue":"2020","key":"2788_CR46","first-page":"8164703","volume":"23","author":"J Konopi\u0144ska","year":"2020","unstructured":"Konopi\u0144ska J, Kozera M, Kra\u015bnicki P, Mariak Z, Rekas M. The effectiveness of first-generation iStent microbypass implantation depends on initial intraocular pressure: 24-month follow-up\u2014prospective clinical trial. J Ophthalmol. 2020;23(2020):8164703.","journal-title":"J Ophthalmol"},{"issue":"1","key":"2788_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.17219\/acem\/129576","volume":"30","author":"M Kozera","year":"2021","unstructured":"Kozera M, Konopi\u0144ska J, R\u0119kas M. Mid-term evaluation of the safety and efficacy of the iStent trabecular micro-bypass system combined with phacoemulsification. Adv Clin Exp Med. 2021;30(1):49\u201354.","journal-title":"Adv Clin Exp Med"},{"issue":"15","key":"2788_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2147\/OPTH.S293637","volume":"10","author":"M Kozera","year":"2021","unstructured":"Kozera M, Konopi\u0144ska J, Mariak Z, R\u0119kas M. Treatment of open-angle glaucoma with iStent implantation combined with phacoemulsification in polish caucasian population. Clin Ophthalmol. 2021;10(15):473\u201380.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"2788_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/IJG.0000000000002141","volume":"32","author":"SR Sarkisian Jr","year":"2023","unstructured":"Sarkisian SR Jr, Grover DS, Gallardo MJ, Brubaker JW, Giamporcaro JE, Hornbeak DM, Katz LJ, Navratil T, iStent infinite Study Group. Effectiveness and safety of iStent infinite trabecular micro-bypass for uncontrolled glaucoma. J Glaucoma. 2023;32(1):9\u201318.","journal-title":"J Glaucoma"},{"issue":"7","key":"2788_CR50","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ophtha.2022.02.021","volume":"129","author":"IIK Ahmed","year":"2022","unstructured":"Ahmed IIK, De Francesco T, Rhee D, McCabe C, Flowers B, Gazzard G, Samuelson TW, Singh K. Long-term outcomes from the HORIZON randomized trial for a Schlemm\u2019s canal microstent in combination cataract and glaucoma surgery. Ophthalmology. 2022;129(7):742\u201351.","journal-title":"Ophthalmology"},{"issue":"5","key":"2788_CR51","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jcrs.2007.12.045","volume":"34","author":"BJ Poley","year":"2008","unstructured":"Poley BJ, Lindstrom RL, Samuelson TW. Long-term effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes. J Cataract Refract Surg. 2008;34(5):735\u201342.","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"2788_CR52","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/01.ijg.0000212294.31411.92","volume":"15","author":"BJ Shingleton","year":"2006","unstructured":"Shingleton BJ, Pasternack JJ, Hung JW, O\u2019Donoghue MW. Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma. 2006;15(6):494\u20138.","journal-title":"J Glaucoma"},{"key":"2788_CR53","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.ophtha.2012.02.050","volume":"119","author":"SL Mansberger","year":"2012","unstructured":"Mansberger SL, Gordon MO, Jampel H, et al. Reduction in intraocular pressure after cataract extraction: the ocular hypertension treatment study. Ophthalmology. 2012;119:1826\u201331.","journal-title":"Ophthalmology"},{"issue":"1","key":"2788_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3928\/1542-8877-19990101-09","volume":"30","author":"DD Kim","year":"1999","unstructured":"Kim DD, Doyle JW, Smith MF. Intraocular pressure reduction following phacoemulsification cataract extraction with posterior chamber lens implantation in glaucoma patients. Ophthalmic Surg Lasers. 1999;30(1):37\u201340.","journal-title":"Ophthalmic Surg Lasers"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02788-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-024-02788-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02788-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T05:35:19Z","timestamp":1711172119000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-024-02788-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2788"],"URL":"https:\/\/doi.org\/10.1007\/s12325-024-02788-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Fritz Hengerer: Research grant and lecture fees from Glaukos Corp (unrelated to study\/publication). Ina Conrad-Hengerer: No disclosures. Gerd U. Auffarth: (1\u2009=\u2009Research Grants; 2\u2009=\u2009Travel Expenses; 3\u2009=\u2009Lecture Fees; 4\u2009=\u2009Consulting). Acufocus3. Alcon (1, 2, 3, 4). AMO\/Johnson&Johnson (1,2,3,4). Biotech (1,3). Carl Zeiss Meditec (1,2,3,4). Contamac (1). Cristalens (1,3,4). Croma (1). Eyebright (3). EyeYon (1,2,4). Hanita (1). Hoya (1,2,3). Kowa (1,2,3). Teleon (1,2,3). Oculus (1,3). Physiol (1). Presbia (4). Rayner (1,2,3,4). Rheacell (1). SIFI (1,2,3,4). Ursapharmc (1,2,3). VSY (1,3,4).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional and\/or national research committee (the Institutional Review Board of the University of Heidelberg [reference #S-482\/2012]), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}